VENROCK ASSOCIATES III LP's Net Worth

-$17.8 Million

Estimate Recalculated Feb 7, 2024 03:58PM EST

Who is VENROCK ASSOCIATES III LP?

VENROCK ASSOCIATES III LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMOS CORP, IMPERVA INC, Coley Pharmaceutical Group, Inc., RENOVIS INC, VOCERA COMMUNICATIONS, INC., Vitae Pharmaceuticals, Inc, INTARCIA THERAPEUTICS, INC, and SIRNA THERAPEUTICS INC.

SEC CIK

VENROCK ASSOCIATES III LP's CIK is 0001119517

Past Insider Trading and Trends

2014 was VENROCK ASSOCIATES III LP's most active year for acquiring shares with 12 total transactions. VENROCK ASSOCIATES III LP's most active month to acquire stocks was the month of August. 2012 was VENROCK ASSOCIATES III LP's most active year for disposing of shares, totalling 9 transactions. VENROCK ASSOCIATES III LP's most active month to dispose stocks was the month of August. 2014 saw VENROCK ASSOCIATES III LP paying a total of $6,178,664.00 for 2,354,203 shares, this is the most they've acquired in one year. In 2012 VENROCK ASSOCIATES III LP cashed out on 3,946,708 shares for a total of $349,458.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHARMOS CORP No price found

Investor

VENROCK ASSOCIATES III LP owns 193,302 units of Common Stock. In the year 2009 VENROCK ASSOCIATES III LP acquired a total of 371,129 shares in PHARMOS CORP at a cost of $20,040.97.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.99%
371.13K
$0.05
$20,040.97
9.67M
May 8
Form 3
—
0
—
—
0
No matching records found

IMPERVA INC No price found

Investor

VENROCK ASSOCIATES III LP owns 2,131,994 units of Common Stock. In the year 2011 VENROCK ASSOCIATES III LP filed a total of 3 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,290.11%
1.98M
—
—
2.13M
Nov 15
Form 4
∞
153.37K
$18.00
$2,760,642.00
153.37K
Nov 9
Form 3
—
0
—
—
0
No matching records found

Coley Pharmaceutical Group, Inc. No price found

Investor

VENROCK ASSOCIATES III LP owns 2,017,630 units of Common Stock. In the year 2005 VENROCK ASSOCIATES III LP filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.02M
—
—
2.02M
Aug 15
Form 3
—
0
—
—
0
No matching records found

RENOVIS INC No price found

Investor

VENROCK ASSOCIATES III LP owns 1,443,206 units of Common Stock. In the year 2004 VENROCK ASSOCIATES III LP filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+39,679.66%
1.44M
—
—
1.44M
Feb 10
Form 3
—
0
—
—
0
No matching records found

VOCERA COMMUNICATIONS, INC. No price found

Investor

VENROCK ASSOCIATES III LP owns 4,693,001 units of Common Stock. In the year 2012 VENROCK ASSOCIATES III LP filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.92%
-696.17K
$24.96
-$349,458.20
4.69M
Nov 19 - Nov 20
Form 4/A
+6.11%
174.98K
$17.78
$3,111,144.40
3.04M
Apr 2
Form 4
∞
2.99M
$17.78
—
2.99M
Apr 2
Form 3
—
0
—
—
0
No matching records found